Cabot Corp. (CBT) Tops Q2 EPS by 2c; misses on guidance
Tweet
Share
E-mail
Get Alerts CBT Hot Sheet
Price: $81.48 --0%
Revenue Growth %: +1.6%
Financial Fact:
Research and technical expenses: 13M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +1.6%
Financial Fact:
Research and technical expenses: 13M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cabot Corp. (NYSE: CBT) reported Q2 EPS of $1.33, $0.02 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $1.11 billion.
GUIDANCE:
Cabot Corp. sees FY2023 EPS of $6.10-$6.50, versus the consensus of $6.45.
For earnings history and earnings-related data on Cabot Corp. (CBT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- HSBC explains why risk assets continue to ignore every negative catalyst
- Citi turns more bullish on trucking stocks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
